Publications by authors named "Josep M Guardiola"

Claim this Profile
S
Sex differences in HIV testing in Catalan emergency departments.
Neus Robert, Emília Miró, Jordi Llaneras, Josep Maria Guardiola, Alejandro Smithson

Eur J Emerg Med· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of new HIV diagnoses achieved in emergency departments using an opt-in strategy, Catalonia, Spain, July 2021 to March 2024.
Jordi Llaneras, Patricia Álvarez-López, Rocío de Paz, Míriam Carbó, Mireia Saura, Josep Maria Guardiola

Euro Surveill· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of emergency departments in HIV screening in Barcelona (Spain) and impact of a targeted opt-in strategy for HIV testing.
Míriam Carbó, Emília Miró, Juan Carlos Hurtado, Agustín Ávila, Neus Robert, Josep Maria Guardiola

Eur J Emerg Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the reasons for requesting HIV serology in the emergency department other than those defined in the targeted screening strategy of the "Urgències VIHgila" program and its potential inclusion in a future consensus document.
Òscar Miró, Emília Miró, Juan González Del Castillo, Míriam Carbó, Alexis Rebollo, Josep Maria Guardiola

Enferm Infecc Microbiol Clin (Engl Ed)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.
Ana Carrero, Juan Berenguer, Víctor Hontañón, Josep M Guardiola, Jordi Navarro

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study.
Òscar Miró, Pere Llorens, Sònia Jiménez, Pascual Piñera, Guillermo Burillo-Putze, Josep Maria Guardiola

Chest· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.
Óscar Brochado, Isidoro Martínez, Juan Berenguer, Luz Medrano, Juan González-García, Josep M Guardiola

J Biomed Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Adriana Gil-Rodrigo, Òscar Miró, Pascual Piñera, Guillermo Burillo-Putze, Sònia Jiménez, Josep María Guardiola

Emergencias· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
Lorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M Guardiola

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
Sonia Vázquez-Morón, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Isabel Canorea, Josep M Guardiola

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.
Pilar Garcia-Broncano, Luz Maria Medrano, Juan Berenguer, Juan González-García, Mª Ángeles Jiménez-Sousa, Josep M Guardiola

Cells· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.
Luz M Medrano, Pilar Garcia-Broncano, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M Guardiola

AIDS· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.
Juan Berenguer, Inmaculada Jarrín, Leire Pérez-Latorre, Víctor Hontañón, María J Vivancos, Josep M Guardiola

Open Forum Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.
Juan Berenguer, Elena Rodríguez-Castellano, Ana Carrero, Miguel A Von Wichmann, Marta Montero, Josep M Guardiola

Hepatology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.
Teresa Aldámiz-Echevarría, Juan González-García, Miguel A Von Wichmann, Manel Crespo, José López-Aldeguer, Josep M Guardiola

Ann Hepatol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.
Montserrat Masip, Laura Tuneu, Neus Pagès, Xavier Torras, Adolfo Gallego, Josep Maria Guardiola

Int J Clin Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.
Luis M Real, Rocío Herrero, Antonio Rivero-Juárez, Ángela Camacho, Juan Macías, Josep M Guardiola

AIDS· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.
Luis M Real, Karin Neukam, Rocío Herrero, Josep M Guardiola, Thomas Reiberger

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Juan Berenguer, Francisco X Zamora, Teresa Aldámiz-Echevarría, Miguel A Von Wichmann, Manel Crespo, Josep M Guardiola

Clin Infect Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.
Douglas Dieterich, Mark Nelson, Vicente Soriano, Keikawus Arastéh, Josep M Guardiola

AIDS· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis.
Juan Berenguer, Francisco X Zamora, Ana Carrero, Miguel A Von Wichmann, Manel Crespo, Josep M Guardiola

J Acquir Immune Defic Syndr· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Juan Berenguer, Julio Alvarez-Pellicer, Ana Carrero, Miguel A Von Wichmann, José López-Aldeguer, Josep M Guardiola

J Hepatol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.
Juan Berenguer, Elena Rodríguez, Pilar Miralles, Miguel A Von Wichmann, José López-Aldeguer, Josep M Guardiola

Clin Infect Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.
Pablo Labarga, Pablo Barreiro, Alfredo da Silva, Josep María Guardiola, Rafael Rubio

J Infect Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy.
Pere Domingo, Josep M Guardiola, Juliana Salazar, Ferran Torres, M Gracia Mateo

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis